Loading company
Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Liminatus Pharma, Inc. and every other company we cover.
Try it first on NVDA, AAPL, META or NKE, where it is open to everyone.
LIMN · Nasdaq · ·
$3.93-5.4%Sep 29 close